Loading quotes...
Forecast
The analysts' average price target is €13.39 (+46.02%). The median is €13.39 (+46.02%).
| Buy |
1 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
Trulieve Cannabis expects quarterly profit and sharp revenue decline
Trulieve Cannabis is expected to open the books for the quarter ended September 30, 2026, on November 5, 2026. Analysts on average expect earnings of $0.093 per share (prior year: -$0.140) on revenue of $221.9 million, a decline of 23.02% from $288.2 million a year earlier. For the current fiscal year, analysts forecast a mean loss per share of -$1.822 (prior year: -$0.610) and revenue of about $1.01 billion (prior year: $1.18 billion). » More on finanzen.net
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 237.41M | 7.37% |
| Gross profit | 142.2M | 8.38% |
| Net profit | -355.8M | 2,943.27% |
| EBITDA | -290.5M | 447.80% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.52B |
Number of shares | 170.16M |
52-week high/low | €11.85 - €4.12 |
| Dividends | No |
Beta | 1.81 |
P/E ratio | -4.08 |
PEG ratio | 0.03 |
P/B ratio | 2.51 |
P/S ratio | 1.49 |
Company profile
| Name | Trulieve Cannabis |
| CEO | Kimberly A. Rivers |
| Employees | 5,000 |
